There is also a significant increase in proportions of MPs in SLE patients with surface bound IgG2, IgM, and C1q, which positively correlates with disease activity, anti-DNA Abs titers and complement activation in patients (110, 111). The gene discussed is CD40LG; the disease is systemic lupus erythematosus.